{
    "2019-12-30": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc.",
                "features": {
                    "keywords": [
                        "Janssen",
                        "Acquisition",
                        "Bermekimab",
                        "XBiotech"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-12-20",
                "original_text": "Will J&J be Able to Overcome Its Legal Troubles in 2020?",
                "features": {
                    "keywords": [
                        "J&J",
                        "Legal",
                        "Troubles"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-02-10",
                "original_text": "The Zacks Analyst Blog Highlights: AbbVie, Abbott Labs, Allergan, Johnson & Johnson and Merck",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "AbbVie",
                        "Abbott Labs",
                        "Allergan",
                        "Johnson & Johnson",
                        "Merck"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-05",
                "original_text": "Zacks.com featured highlights include: Johnson & Johnson, Gibraltar Industries, Omnicell, MDU Resources and Career Education",
                "features": {
                    "keywords": [
                        "Zacks.com",
                        "highlights",
                        "Johnson & Johnson",
                        "Gibraltar Industries",
                        "Omnicell",
                        "MDU Resources",
                        "Career Education"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}